Stay updated with breaking news from Barry Selick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief...
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge...
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development - read this article along with other careers information, tips and advice on BioSpace
Published: Dec 21, 2020 Autobahn Labs and UCSF will establish new ventures for drug discovery and development PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of s...
UCSF and BridgeBio Pharma to Accelerate Therapies for Genetic Diseases By Nicholas Weiler on December 22, 2020 SAN FRANCISCO – December 23, 2020 - UC San Francisco and BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients. “The BridgeBio team is developing close relationships with our investigators at UCSF with the mission of bringing potential therapies into the clinic quickly, where they have the opportunity to help patients in need,” said Barry Selic...